Involve representatives in the working group process to draft the reform policy

Wholesale Drugstores: (No position or change)

25

0

0

Limited access to pharmaceutical products

Health Insurance Funds: Position strengthened to High Opposition

50

50

25

Limited access to pharmaceutical products

Media and Press: Position weakened to Medium Opposition

25

25

25

Limited access to pharmaceutical products

Ministry of Development & Competitiveness: Position weakened to Non-Mobilized

50

50

25

Limited access to pharmaceutical products

Ministry of Employment and Social Protection: Position weakened to Non-Mobilized and strengthened to Medium

50

50

25

Limited access to pharmaceutical products

Ministry of Finance: (No position or change)

50

50

25

Limited access to pharmaceutical products

Ministry of Health: Position strengthened to High Opposition

50

50

25

Organize a media campaign to create a sense of public “crisis” regarding access to and costs of pharmaceutical products, in order to justify major policy aims and override opposition.

Citizens-Patients-Customers: Position strengthened to Medium Opposition

100

75

75

Organize a media campaign to create a sense of public “crisis” regarding access to and costs of pharmaceutical products, in order to justify major policy aims and override opposition.

Media and Press: (No position or change)

50

25

25

Organize a media campaign to create a sense of public “crisis” regarding access to and costs of pharmaceutical products, in order to justify major policy aims and override opposition.

Political Parties: Position strengthened to Low Opposition

50

25

25

Organizing a media campaign or finding sympathetic victims

Citizens-Patients-Customers: (No position or change)

75

50

50

Organizing a media campaign or finding sympathetic victims

Political Parties: Position weakened to Medium Support

50

25

25

Persuade single-payer proponents that the policy is the best plan they could hope to achieve

Health Insurance Funds: (No position or change)

50

25

25

Provide compensation for real and perceived harms

Medical Association―Doctors: Position weakened to Low Support

25

0

0

Provide compensation for real and perceived harms

Pharmaceutical Industries: Position weakened to Low Support

50

25

0

Provide compensation for real and perceived harms

Pharmacy Chains: Position weakened to Medium Support and strengthened to High

50

25

25

Provide compensation for real and perceived harms

Wholesale Drugstores: (No position or change)

50

25

0

Provide information and evidence, including technical and political information.

Universities: (No position or change)

75

50

50

Providing incentives, removing objections, or adding desired policy elements.

Citizens-Patients-Customers: (No position or change)

50

50

50